Clinical Dataset of 56 Myelofibrosis Patients (PMF and SMF) at Tianjin Medical University General Hospital (2017–2022)

Read full text Summarise with VIRAT
Authors: Wenya Liu
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

This dataset contains de-identified clinical data for 56 patients diagnosed with myelofibrosis (MF), collected at Tianjin Medical University General Hospital between May 2017 and March 2022. The study was approved by the Institutional Ethics Committee of Tianjin Medical University General Hospital and conducted in accordance with the Declaration of Helsinki; informed consent was waived due to the retrospective design. The dataset is divided into two subsets: 33 patients with Primary Myelofibrosis (PMF), diagnosed according to WHO 2016 criteria 23 patients with Secondary Myelofibrosis (SMF) transformed from Polycythemia Vera (PV) or Essential Thrombocythemia (ET) Inclusion criteria: age ≥18 years; confirmed MF diagnosis by bone marrow biopsy, laboratory tests, and genetic testing; complete key clinical records.Exclusion criteria: therapy-related or other secondary MF; severe organ failure; participation in other interfering clinical trials. Variables include: Demographics: gender, age Clinical assessment: risk scores (MIPSS‑70 V2 for PMF, MYSEC‑PM for SMF), splenomegaly, symptoms Laboratory tests: blood routine, LDH, D‑dimer, BNP, iron metabolism, EPO, folate, vitamin B12 Bone marrow: smear, biopsy, fibrosis grade (0–4+), karyotype, FISH Genetics: driver mutations (JAK2, CALR, MPL) and non‑driver mutations Treatment: ruxolitinib, interferon, hydroxyurea, supportive care Follow‑up: survival status, follow‑up duration, outcome events Missing data are coded as “Not tested” or “NA”. Key variables have missing rate

Fields of Study & Subjects

Myeloproliferative Neoplasms: Diagnosis and Treatment Hematological disorders and diagnostics Acute Myeloid Leukemia Research

Publication details

Journal / source
Figshare
Publication date
1 January 2026
Language
EN